Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Intervention Program topic

No spam. Unsubscribe anytime.

Executive officer tells IEC board motion limits requiring patient care or narcotics access for program completion

5692068 · August 27, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Loretta Melby, executive officer, reviewed a board motion and evidence standards for the intervention program, saying the board suspended automatic requirements that program participants work in direct patient care or pass narcotics unless additional patient‑safety evidence is presented.

Loretta Melby, executive officer for the Intervention Evaluation Committee, told members on Aug. 26 that the board’s motion from the prior year suspended a blanket requirement that intervention‑program participants be required to work in direct patient care or to pass narcotics as a condition of program completion unless there is additional evidence of a patient‑safety risk.

Melby said the change responds to public concerns and inconsistent messaging from a prior vendor, and that the committee must document evidence whenever it recommends imposing or removing those requirements. “The motion that was put forward by our board in August said to suspend the imposition of the requirement that participants work in direct patient care unless there is an additional evidence of patient safety issues,” Melby said.

The explanation came during an information item on program participation and completion requirements. Melby told the Intervention Evaluation Committee (IEC) that since the board motion took effect the executive office has reviewed 56 IEC recommendations for completion that involved direct patient care or narcotic access. Of those, she said, she upheld 19 recommendations as supported by evidence and returned 31 to IECs for reconsideration because the documentation did not show additional patient‑safety issues or raised questions about how the recommendation was reached.

Why it matters: the IECs review nurses in the board’s alternative‑to‑discipline intervention program and recommend terms for return to practice. Melby emphasized that the board’s authority does not allow a blanket rule requiring narcotics access or direct patient care for all participants; such conditions must be justified by evidence specific to the individual case.

Melby reviewed how the board and the program assess readiness to return to practice. She said the program runs three to five years and relies on clinical evaluations, vendor case managers (currently Premier Health), work‑site monitoring and drug testing. “If they’re showing that they’re working their program, if they’re showing that they’ve got the support and they can continue to be, as much as we can determine, sober or in control their mental health, we have the ability to review them for completion,” Melby said.

Committee members pressed for clarity on what constitutes the “additional evidence of patient safety issues” that would justify requiring direct patient care or narcotics access. Melby said reviewers should examine root causes, treatment engagement, recent program compliance (for example missed calls or a problematic worksite monitor report), and clinical evaluator findings. “You look at root root cause. Right? What is what is the root cause of that? The root cause of that is the addiction,” Melby said, adding that the program’s goal is to give participants the tools to manage a lifelong condition.

Melby also said the board participates in a National Council of State Boards of Nursing study tracking completions and longer‑term recidivism; she said the study is in its final two years and will provide additional evidence about outcomes for participants who complete the program without mandated direct patient care or narcotics access.

Committee members raised concerns that some job roles commonly require narcotics access and asked how the committee can be confident a participant will not later encounter risks if placed in those roles. Melby responded that clinical evaluators, ongoing monitoring and worksite reports are intended to create a controlled, stepped return to practice when appropriate and that participants who successfully complete can re‑enter the program if they later need help.

Melby told IEC members the office will increase training and transparency, record and post IEC open sessions going forward, and continue outreach materials; she provided her contact email, loretta.melby@dca.ca.gov, for follow‑up.

Ending: The IEC did not take a committee vote on changing program standards at this meeting; Melby said staff will continue to present education to IECs and to return cases to committees when documentation is incomplete.